TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive President’s Budget Takes Care If R01s, P01s, Fattens Up NTP, Devastates Construction Grants February 1, 1980
TCL Archive House Encourages NCI To continue Leadership Role As Coordinator Of Cancer Program October 8, 1999
TCL Archive In Brief: An Era Ends – Lee Clark Retires After 32 Years As Head Of UT Center; Lemaistre Succeeds Him August 4, 1978
